Ignace Vergote
Impact in
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 0.01%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 514
- Endometriosis Research and Treatment 60
-
- Endometrial and Cervical Cancer Treatments 258
- Uterine Myomas and Treatments 86
- Co-authors
- Frédéric AmantD. TimmermanPatrick NevenCharlie GourleyPhilippe MoermanAmit M. OzaToon Van GorpStéphanie Lheureux
- Journals
- Journal of Clinical Oncology (159 papers)International Journal of Gynecological Cancer (122 papers)Gynecologic Oncology (98 papers)Annals of Oncology (65 papers)European Journal of Cancer (41 papers)
- Partner nations
- BelgiumGermanyUnited States
In The Last Decade
Ignace Vergote
873 papers receiving 37.5k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Reproductive Medicine 21.6k
- Obstetrics and Gynecology 12.7k
- Oncology 13.5k
- Cancer Research 5.2k
- Surgery 9.3k
Countries citing papers authored by Ignace Vergote
This map shows the geographic impact of Ignace Vergote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignace Vergote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignace Vergote more than expected).
Fields of papers citing papers by Ignace Vergote
This network shows the impact of papers produced by Ignace Vergote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignace Vergote. The network helps show where Ignace Vergote may publish in the future.
Co-authors
The 25 scholars most cited alongside Ignace Vergote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 9 | |
| 10 | 2018 | 3 | |
| 11 | 2018 | 20 | |
| 12 | The immune system as a biomarker in ovarian cancer diagnosis | 2017 | 1 |
| 13 | 2016 | 78 | |
| 14 | Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial Hit paper breakdown → | 2014 | 1117 |
| 15 | 2013 | 34 | |
| 16 | 2011 | 378 | |
| 17 | 2011 | 30 | |
| 18 | 2011 | 1 | |
| 19 | Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse Hit paper breakdown → | 2010 | 410 |
| 20 | Incidence and prevalence of hysterectomy in the Flemish Region (Belgium) | 1999 | 1 |
About Ignace Vergote
Ignace Vergote is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 899 papers that have together received 38.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (514 papers), Endometrial and Cervical Cancer Treatments (258 papers), Intraperitoneal and Appendiceal Malignancies (124 papers), PARP inhibition in cancer therapy (111 papers), Uterine Myomas and Treatments (86 papers), BRCA gene mutations in cancer (61 papers), Endometriosis Research and Treatment (60 papers) and Estrogen and related hormone effects (54 papers). The work is most often cited by research in Reproductive Medicine (21.6k citations), Obstetrics and Gynecology (12.7k citations), Oncology (13.5k citations), Cancer Research (5.2k citations) and Surgery (9.3k citations). Ignace Vergote has collaborated with scholars based in Belgium, Germany and United States. Frequent co-authors include Frédéric Amant, D. Timmerman, Patrick Neven, Charlie Gourley, Philippe Moerman, Amit M. Oza, Toon Van Gorp, Stéphanie Lheureux, Gunnar B. Kristensen and Erik Van Limbergen. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.